FDA.reportPublic FDA data

Rituxan Hycela 1400 MG / 23,400 UNT in 11.7 ML Injection

RxCUI
1927890
RxNorm name
Rituxan Hycela 1400 MG / 23,400 UNT in 11.7 ML Injection
Display name
Rituxan Hycela 1400 MG / 23,400 UNT in 11.7 ML Injection
Full name
Rituxan Hycela 1400 MG / 23,400 UNT in 11.7 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:55

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761064Rituxan Hycelarituximab and hyaluronidase human351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
3e5b7e82-f018-4eaf-ae78-d6145a906b20Rituxan Hycela 1400 MG / 23,400 UNT in 11.7 ML Injection [PSN] · 11.7 ML hyaluronidase, human recombinant 2000 UNT/ML / rituximab 120 MG/ML Injection [Rituxan Hycela] [SBD] · Rituxan Hycela 1400 MG / 23,400 UNT per 11.7 ML Injection [SY]321These highlights do not include all the information needed to use RITUXAN HYCELA safely and effectively. See full prescribing information for RITUXAN HYCELA. RITUXAN HYCELA ® (rituximab and hyaluronidase human) injection, for subcutaneous use Initial U.S. Approval: 201720251215